Cytochrome P-450 Enzyme Inhibitors

DBCAT000394Pharmacologic class

Drugs and compounds which inhibit or antagonize the biosynthesis or actions of CYTOCHROME P-450 ENZYMES. A DrugBank category of 810 drugs. 655 of them are approved.

Also known as
Cytochrome P 450 Dependent Monooxygenase Inhibitors · Cytochrome P 450 Enzyme Inhibitors · Cytochrome P 450 Inhibitors · Cytochrome P 450 Monooxygenase Inhibitors · Cytochrome P 450 Oxygenase Inhibitors

What you can answer from here — as of December 17, 2018

810DrugsEach linked to its full drug card
Sign in
1,415Drug targetsEvery drug–target pair in the class, with bond type
Sign in
250,487Marketed productsAcross the regions we cover, with dosage forms and routes
Sign in
71Routes of administrationHow the drugs in this class are given
Sign in
10SubcategoriesNarrower classes within this one
Sign in

Which targets do Cytochrome P-450 Enzyme Inhibitors share, and which companies have late-stage candidates in this class?

Create a free account or log in to explore the full data card.

Create Account